Clinical Trials Browser

Phase 1/2 × Bone Metastases × Docetaxel × Clear all

NCT01106352 2017-01-04

A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)

Phase 1/2 Completed

70 enrolled 26 charts

Bone Metastases